Chengdu Suncadia Medicine Co., Ltd.

This study tested whether a new capsule medication called HRS-5965 works as well as the standard treatment (eculizumab) for people with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder. The trial involved 76 patients who took either treatment for 24 weeks. Researc…

This Phase 3 trial tested whether HRS-5965 capsules could help patients with paroxysmal nocturnal hemoglobinuria (PNH) who continue to have anemia despite already receiving standard C5 inhibitor treatments like eulizumab. The study involved 39 adults who took the capsules for 24 …

This early-stage study aimed to see if the body absorbs an experimental drug the same way when it's in a capsule versus a tablet. It involved 16 healthy male volunteers who took both forms of the drug on an empty stomach. The main goal was to compare how much of the drug gets int…

This early-stage study tested how a single dose of the experimental drug HRS-5965 behaves in people with and without liver problems. It involved 24 adults with kidney disease to see if liver function changes how the drug is processed in the body and to check for safety. The goal …